340 related articles for article (PubMed ID: 9851705)
1. The N-terminal region of non-A beta component of Alzheimer's disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils.
El-Agnaf OM; Bodles AM; Guthrie DJ; Harriott P; Irvine GB
Eur J Biochem; 1998 Nov; 258(1):157-63. PubMed ID: 9851705
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of non-abeta component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of beta-sheet structure and fibrils.
Bodles AM; Guthrie DJ; Harriott P; Campbell P; Irvine GB
Eur J Biochem; 2000 Apr; 267(8):2186-94. PubMed ID: 10759841
[TBL] [Abstract][Full Text] [Related]
3. Identification of the region of non-Abeta component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity.
Bodles AM; Guthrie DJ; Greer B; Irvine GB
J Neurochem; 2001 Jul; 78(2):384-95. PubMed ID: 11461974
[TBL] [Abstract][Full Text] [Related]
4. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
6. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
Satheeshkumar KS; Jayakumar R
Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
[TBL] [Abstract][Full Text] [Related]
7. The influence of the central region containing residues 19-25 on the aggregation properties and secondary structure of Alzheimer's beta-amyloid peptide.
El-Agnaf OM; Guthrie DJ; Walsh DM; Irvine GB
Eur J Biochem; 1998 Sep; 256(3):560-9. PubMed ID: 9780232
[TBL] [Abstract][Full Text] [Related]
8. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
[TBL] [Abstract][Full Text] [Related]
9. Effect of pH on the aggregate formation of a non-amyloid component (1-13).
Abe H; Nakanishi H
J Pept Sci; 2003 Mar; 9(3):177-86. PubMed ID: 12675500
[TBL] [Abstract][Full Text] [Related]
10. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
Satheeshkumar KS; Murali J; Jayakumar R
J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
[TBL] [Abstract][Full Text] [Related]
11. Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic.
Iwai A; Yoshimoto M; Masliah E; Saitoh T
Biochemistry; 1995 Aug; 34(32):10139-45. PubMed ID: 7640267
[TBL] [Abstract][Full Text] [Related]
12. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
Cottingham MG; Hollinshead MS; Vaux DJ
Biochemistry; 2002 Nov; 41(46):13539-47. PubMed ID: 12427014
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
Kapurniotu A; Schmauder A; Tenidis K
J Mol Biol; 2002 Jan; 315(3):339-50. PubMed ID: 11786016
[TBL] [Abstract][Full Text] [Related]
14. Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP?
Abedini A; Raleigh DP
J Mol Biol; 2006 Jan; 355(2):274-81. PubMed ID: 16303136
[TBL] [Abstract][Full Text] [Related]
15. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
16. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
[TBL] [Abstract][Full Text] [Related]
17. The effects of aggregation-inducing motifs on amyloid formation of model proteins related to neurodegenerative diseases.
Tanaka M; Machida Y; Nishikawa Y; Akagi T; Morishima I; Hashikawa T; Fujisawa T; Nukina N
Biochemistry; 2002 Aug; 41(32):10277-86. PubMed ID: 12162743
[TBL] [Abstract][Full Text] [Related]
18. Solution conformation and amyloid-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet.
Ohnishi S; Koide A; Koide S
J Mol Biol; 2000 Aug; 301(2):477-89. PubMed ID: 10926522
[TBL] [Abstract][Full Text] [Related]
19. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.
McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE
Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407
[TBL] [Abstract][Full Text] [Related]
20. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?
Han H; Weinreb PH; Lansbury PT
Chem Biol; 1995 Mar; 2(3):163-9. PubMed ID: 9383418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
